BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 27595568)

  • 1. Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs.
    Oberle CS; Joos B; Rusert P; Campbell NK; Beauparlant D; Kuster H; Weber J; Schenkel CD; Scherrer AU; Magnus C; Kouyos R; Rieder P; Niederöst B; Braun DL; Pavlovic J; Böni J; Yerly S; Klimkait T; Aubert V; Trkola A; Metzner KJ; Günthard HF;
    Retrovirology; 2016 Sep; 13(1):62. PubMed ID: 27595568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infant transmitted/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma.
    Kumar A; Smith CEP; Giorgi EE; Eudailey J; Martinez DR; Yusim K; Douglas AO; Stamper L; McGuire E; LaBranche CC; Montefiori DC; Fouda GG; Gao F; Permar SR
    PLoS Pathog; 2018 Apr; 14(4):e1006944. PubMed ID: 29672607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced Potency and Incomplete Neutralization of Broadly Neutralizing Antibodies against Cell-to-Cell Transmission of HIV-1 with Transmitted Founder Envs.
    Li H; Zony C; Chen P; Chen BK
    J Virol; 2017 May; 91(9):. PubMed ID: 28148796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic properties of envelope glycoproteins of transmitted HIV-1 variants from patients belonging to transmission chains.
    Beretta M; Moreau A; Bouvin-Pley M; Essat A; Goujard C; Chaix ML; Hue S; Meyer L; Barin F; Braibant M;
    AIDS; 2018 Sep; 32(14):1917-1926. PubMed ID: 29927786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genetic bottleneck in vertical transmission of subtype C HIV-1 is not driven by selection of especially neutralization-resistant virus from the maternal viral population.
    Russell ES; Kwiek JJ; Keys J; Barton K; Mwapasa V; Montefiori DC; Meshnick SR; Swanstrom R
    J Virol; 2011 Aug; 85(16):8253-62. PubMed ID: 21593171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of a Tier-1-Like Phenotype in Diverse Tier-2 Isolates by Agents That Guide HIV-1 Env to Perturbation-Sensitive, Nonnative States.
    Johnson J; Zhai Y; Salimi H; Espy N; Eichelberger N; DeLeon O; O'Malley Y; Courter J; Smith AB; Madani N; Sodroski J; Haim H
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28490588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of human immunodeficiency virus type 1 (HIV-1) diversity and tropism in 145 patients with primary HIV-1 infection.
    Rieder P; Joos B; Scherrer AU; Kuster H; Braun D; Grube C; Niederöst B; Leemann C; Gianella S; Metzner KJ; Böni J; Weber R; Günthard HF
    Clin Infect Dis; 2011 Dec; 53(12):1271-9. PubMed ID: 21998286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic and immunologic comparison of clade B transmitted/founder and chronic HIV-1 envelope glycoproteins.
    Wilen CB; Parrish NF; Pfaff JM; Decker JM; Henning EA; Haim H; Petersen JE; Wojcechowskyj JA; Sodroski J; Haynes BF; Montefiori DC; Tilton JC; Shaw GM; Hahn BH; Doms RW
    J Virol; 2011 Sep; 85(17):8514-27. PubMed ID: 21715507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postnatally-transmitted HIV-1 Envelope variants have similar neutralization-sensitivity and function to that of nontransmitted breast milk variants.
    Fouda GG; Mahlokozera T; Salazar-Gonzalez JF; Salazar MG; Learn G; Kumar SB; Dennison SM; Russell E; Rizzolo K; Jaeger F; Cai F; Vandergrift NA; Gao F; Hahn B; Shaw GM; Ochsenbauer C; Swanstrom R; Meshnick S; Mwapasa V; Kalilani L; Fiscus S; Montefiori D; Haynes B; Kwiek J; Alam SM; Permar SR
    Retrovirology; 2013 Jan; 10():3. PubMed ID: 23305422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of the Envelope Glycoprotein of HIV-1 Clade B toward Higher Infectious Properties over the Course of the Epidemic.
    Bouvin-Pley M; Beretta M; Moreau A; Roch E; Essat A; Goujard C; Chaix ML; Moiré N; Martin L; Meyer L; Barin F; Braibant M
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30567994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of neutralizing and enhancing antibodies to human immunodeficiency virus type 1 primary isolates in plasma of individuals infected with env Genetic subtype B and E viruses in Thailand.
    Auewarakul P; Louisirirotchanakul S; Sutthent R; Taechowisan T; Kanoksinsombat C; Wasi C
    Viral Immunol; 1996; 9(3):175-85. PubMed ID: 8890476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic deficits in the HIV-1 envelope are associated with the maturation of a V2-directed broadly neutralizing antibody lineage.
    Reh L; Magnus C; Kadelka C; Kühnert D; Uhr T; Weber J; Morris L; Moore PL; Trkola A
    PLoS Pathog; 2018 Jan; 14(1):e1006825. PubMed ID: 29370298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conserved molecular signatures in gp120 are associated with the genetic bottleneck during simian immunodeficiency virus (SIV), SIV-human immunodeficiency virus (SHIV), and HIV type 1 (HIV-1) transmission.
    Gonzalez MW; DeVico AL; Lewis GK; Spouge JL
    J Virol; 2015 Apr; 89(7):3619-29. PubMed ID: 25589663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sexually-transmitted/founder HIV-1 cannot be directly predicted from plasma or PBMC-derived viral quasispecies in the transmitting partner.
    Frange P; Meyer L; Jung M; Goujard C; Zucman D; Abel S; Hochedez P; Gousset M; Gascuel O; Rouzioux C; Chaix ML;
    PLoS One; 2013; 8(7):e69144. PubMed ID: 23874894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
    Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations that confer resistance to broadly-neutralizing antibodies define HIV-1 variants of transmitting mothers from that of non-transmitting mothers.
    Kumar A; Giorgi EE; Tu JJ; Martinez DR; Eudailey J; Mengual M; Honnayakanahalli Marichannegowda M; Van Dyke R; Gao F; Permar SR
    PLoS Pathog; 2021 Apr; 17(4):e1009478. PubMed ID: 33798244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Envelope Cytoplasmic Tail of HIV-1 Subtype C Contributes to Poor Replication Capacity through Low Viral Infectivity and Cell-to-Cell Transmission.
    Santos da Silva E; Mulinge M; Lemaire M; Masquelier C; Beraud C; Rybicki A; Servais JY; Iserentant G; Schmit JC; Seguin-Devaux C; Perez Bercoff D
    PLoS One; 2016; 11(9):e0161596. PubMed ID: 27598717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterosexual Transmission of Subtype C HIV-1 Selects Consensus-Like Variants without Increased Replicative Capacity or Interferon-α Resistance.
    Deymier MJ; Ende Z; Fenton-May AE; Dilernia DA; Kilembe W; Allen SA; Borrow P; Hunter E
    PLoS Pathog; 2015 Sep; 11(9):e1005154. PubMed ID: 26378795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparisons of the genetic and neutralization properties of HIV-1 subtype C and CRF07/08_BC env molecular clones isolated from infections in China.
    Wang S; Nie J; Wang Y
    Virus Res; 2011 Jan; 155(1):137-46. PubMed ID: 20875470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmission of Multiple HIV-1 Subtype C Transmitted/founder Viruses into the Same Recipients Was not Determined by Modest Phenotypic Differences.
    Song H; Hora B; Giorgi EE; Kumar A; Cai F; Bhattacharya T; Perelson AS; Gao F
    Sci Rep; 2016 Dec; 6():38130. PubMed ID: 27909304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.